Richard lost 25 kgs (3.9 stone) in 6 months with the Elipse Weight Loss Program

Discover everything about the Elipse Programme: https://allurion.com/en

Because of work and a sedentary lifestyle, Richard gained weight, up to 115 kgs (18.1 stone). Wanting to change, he tried several diets before finding about the Elipse gastric balloon. From the placement to his final results, he shares his whole story. In the end, Richard lost 25 kgs thanks to the Elipse Program.

A temporary balloon does not mean temporary weight loss. The Elipse Balloon takes up space in your stomach and induces weight loss by increasing the feeling of fullness. This means that you are more likely to reduce the amount of food you eat throughout the day. (2) It does not require surgery, endoscopy*, or anaesthesia. Lose an average of 10 to 15kg (1.57 to 2.36 stone) during your 16-week placement with support from a nutritionist and our connected app and scale. (2 - 12)

The Elipse Balloon is a revolutionary gastric balloon that creates a feeling of fullness by taking up space in your stomach. It gives you the chance to take a ‘honeymoon from hunger’. (1) A fully supported programme with healthcare professionals on hand to help you change your lifestyle habits.


Results may vary from one patient to another. A small percentage of patients don’t respond to the treatment.

*In rare cases, the Elipse Balloon may require endoscopic or surgical intervention for removal. In rare cases, the empty balloon may be vomited instead of passing through the GI tract.

1 Quote from Lucy Jones, dietician http://www.lucyjonesdietitian.co.uk/
2 Jamal et al. Obes Surg. 2019 Apr;29(4):1236-1241.
3 Clinical Trial Reports: DAA069 and DAA105
4 Raftopoulos and Giannakou. SOARD. 2017 Jul;13(7):1174-1182.
5 Al Sabah, S., et al. SOARD. 2018, 14(3), 311-317.
6 Machytka E et al. Endoscopy. 2017 Feb;49(2):154-160.
7 Genco et al. Obes Surg 2017,DOI 10.1007/s11695-017-2877-1
8 Al-Subaie S et al. Int J Surg. 2017 Dec;48:16-22.
9 Ienca et al. Submitted to SOARD. Abstract A278, presented at Obesity Week, 2018, Nashville, USA
10 Genco et al. Abstract A185. Oral Presentation at Obesity Week, 2018, Nashville, USA
11 Ienca et al. Abstract 237, presented at IFSO 2019, Madrid, Spain
12 Raftopoulos et al. Abstract 1978. Presented at ACS 2019, San Francisco, United States